SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0000945621-10-000196
Filing Date
2010-11-17
Accepted
2010-11-17 16:15:47
Documents
1
Effectiveness Date
2010-11-17
Items
Item 06: Rule 506
Item 3C: Investment Company Act Section 3(c)
Item 3C.1: Section 3(c)(1)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 8378
  Complete submission text file 0000945621-10-000196.txt   10334
Mailing Address C/O ESSEX INVESTMENT MANAGEMENT CO., LLC 125 HIGH ST., 29TH FLOOR BOSTON MA 02110
Business Address C/O ESSEX INVESTMENT MANAGEMENT CO., LLC 125 HIGH ST., 29TH FLOOR BOSTON MA 02110 617-342-3200
Essex Global Life Sciences Fund, LP (a Series of Essex Specialty Pooled Funds, L.P.) (Filer) CIK: 0001505786 (see all company filings)

IRS No.: 043400565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-150594 | Film No.: 101200012